Latest Blogs

new PBAC approvals pertuzumab and trastuzumab emtasine

POEMS study

Hi all. 

It has been a while since last comments. San Antonio was a bust with me recovering from flu. Anyway, one of the best recent study outcomes was the POEMS study (http://www.nejm.org/doi/full/10.1056/NEJMoa1413204). This randomised study demonstrated conclusively that the hormonal implant goserelin can protect the ovarian function and therefore fertility during chemotherapy. This has huge ramifications for women receiving chemotherapy who still want to bear children or those wanting to avoid an early menopause. It is not government funded and will cost about between 700-1800$ depending on the length of the chemotherapy course.

It generates a temporary  menopause or hibernation of the ovaries if you prefer. Side effects may include hot flushes, mood disturbance and loss of libido.